Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Modulation of inflammatory response in a cirrhotic rat model with induced bacterial peritonitis.

Sánchez E, Francés R, Soriano G, Mirelis B, Sancho FJ, González-Navajas JM, Muñoz C, Song XY, Pérez-Mateo M, Such J, Guarner C.

PLoS One. 2013;8(3):e59692. doi: 10.1371/journal.pone.0059692. Epub 2013 Mar 20.

2.

Development of an experimental model of induced bacterial peritonitis in cirrhotic rats with or without ascites.

Sánchez E, Such J, Chiva MT, Soriano G, Llovet T, Mercè J, Sancho F, Muñoz C, Song XY, Pérez-Mateo M, Balanzó J, Guarner C.

Am J Gastroenterol. 2007 Jun;102(6):1230-6.

PMID:
17531011
3.

Bacterial translocation is downregulated by anti-TNF-alpha monoclonal antibody administration in rats with cirrhosis and ascites.

Francés R, Chiva M, Sánchez E, González-Navajas JM, Llovet T, Zapater P, Soriano G, Muñoz C, Balanzó J, Pérez-Mateo M, Song XY, Guarner C, Such J.

J Hepatol. 2007 May;46(5):797-803. Epub 2006 Dec 27.

PMID:
17321632
4.

Effects of pentoxifylline on intestinal bacterial overgrowth, bacterial translocation and spontaneous bacterial peritonitis in cirrhotic rats with ascites.

Corradi F, Brusasco C, Fernández J, Vila J, Ramirez MJ, Seva-Pereira T, Fernández-Varo G, Mosbah IB, Acevedo J, Silva A, Rocco PR, Pelosi P, Gines P, Navasa M.

Dig Liver Dis. 2012 Mar;44(3):239-44. doi: 10.1016/j.dld.2011.10.014. Epub 2011 Nov 25.

PMID:
22119621
5.
6.

Effect of intravenous albumin on endotoxin removal, cytokines, and nitric oxide production in patients with cirrhosis and spontaneous bacterial peritonitis.

Chen TA, Tsao YC, Chen A, Lo GH, Lin CK, Yu HC, Cheng LC, Hsu PI, Tsai WL.

Scand J Gastroenterol. 2009;44(5):619-25. doi: 10.1080/00365520902719273.

PMID:
19191184
7.

Randomized trial comparing ceftriaxone with cefonicid for treatment of spontaneous bacterial peritonitis in cirrhotic patients.

Gómez-Jiménez J, Ribera E, Gasser I, Artaza MA, Del Valle O, Pahissa A, Martínez-Vázquez JM.

Antimicrob Agents Chemother. 1993 Aug;37(8):1587-92.

8.

Five days of ceftriaxone to treat spontaneous bacterial peritonitis in cirrhotic patients.

França A, Giordano HM, Sevá-Pereira T, Soares EC.

J Gastroenterol. 2002;37(2):119-22.

PMID:
11871762
9.

Failure of prophylactic and therapeutic use of a murine anti-tumor necrosis factor monoclonal antibody in Escherichia coli sepsis in the rabbit.

Stack AM, Saladino RA, Thompson C, Sattler F, Weiner DL, Parsonnet J, Nariuchi H, Siber GR, Fleisher GR.

Crit Care Med. 1995 Sep;23(9):1512-8.

PMID:
7664553
10.
11.

Oral ciprofloxacin versus intravenous cefotaxime and ceftriaxone in the treatment of spontaneous bacterial peritonitis.

Tuncer I, Topcu N, Durmus A, Turkdogan MK.

Hepatogastroenterology. 2003 Sep-Oct;50(53):1426-30.

PMID:
14571754
12.

Long-term prognosis of cirrhosis after spontaneous bacterial peritonitis treated with ceftriaxone.

França AV, De Souza JB, Silva CM, Soares EC.

J Clin Gastroenterol. 2001 Oct;33(4):295-8.

PMID:
11588542
13.

The effect of granulocyte colony-stimulating factor in the treatment of Escherichia coli peritonitis with or without ceftriaxone in a nonneutropenic rat model.

Saba R, Güler M, Inan D, Oğünç D, Atalay S, Mamikoğlu L, Günseren F.

Surg Today. 2003;33(7):504-8.

PMID:
14506994
14.

The efficacy and the immunomodulatory effect of rifaximin in prophylaxis of spontaneous bacterial peritonitis in cirrhotic Egyptian patients.

Mostafa T, Badra G, Abdallah M.

Turk J Gastroenterol. 2015 Mar;26(2):163-9. doi: 10.5152/tjg.2015.7782.

15.

Inhibition of splenic macrophage tumor necrosis factor alpha secretion in vivo by antilipopolysaccharide monoclonal antibodies.

Battafarano RJ, Burd RS, Kurrelmeyer KM, Ratz CA, Dunn DL.

Arch Surg. 1994 Feb;129(2):179-80.

PMID:
8304828
16.

Effects of lipopolysaccharide on TNF-alpha production, hepatic NOS2 activity, and hepatic toxicity in rats with cirrhosis.

Heller J, Sogni P, Barrière E, Tazi KA, Chauvelot-Moachon L, Guimont MC, Bories PN, Poirel O, Moreau R, Lebrec D.

J Hepatol. 2000 Sep;33(3):376-81.

PMID:
11019992
17.

Carbon dioxide pneumoperitoneum induces anti-inflammatory response and hepatic oxidative stress in young rats with bacterial peritonitis.

Hsieh CS, Tain YL, Chen YC, Chang K, Jean YH, Huang LT.

Pediatr Surg Int. 2011 Mar;27(3):289-94. doi: 10.1007/s00383-010-2801-4. Epub 2010 Nov 26.

PMID:
21110033
18.

Reduction of carbon tetrachloride-induced rat liver injury by IRFI 042, a novel dual vitamin E-like antioxidant.

Campo GM, Squadrito F, Ceccarelli S, Calò M, Avenoso A, Campo S, Squadrito G, Altavilla D.

Free Radic Res. 2001 Apr;34(4):379-93.

PMID:
11328674
19.

Tyrosine kinase inhibition ameliorates the hyperdynamic state and decreases nitric oxide production in cirrhotic rats with portal hypertension and ascites.

López-Talavera JC, Levitzki A, Martínez M, Gazit A, Esteban R, Guardia J.

J Clin Invest. 1997 Aug 1;100(3):664-70.

20.

Divergent efficacy of antibody to tumor necrosis factor-alpha in intravascular and peritonitis models of sepsis.

Bagby GJ, Plessala KJ, Wilson LA, Thompson JJ, Nelson S.

J Infect Dis. 1991 Jan;163(1):83-8.

PMID:
1984480

Supplemental Content

Support Center